Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development
The latest study from the Malaria Lab focuses on developing the next generation of malaria vaccines using genetically attenuated parasites (GAPs). By deleting two crucial genes for Plasmodium liver stage development, we demonstrate that our PbHscB-PbMei2 double-knockout (2-KO) parasite line results in a complete developmental arrest at this critical stage.
This groudbreaking discovery paves the way for future vaccine designs targeting the Plasmodium liver stage, thereby preventing the symptomatic blood phase of malaria.
Melanie Schmid*, Raphael Beyeler*, Reto Caldelari, Ruth Rehmann, Volker Heussler and Magali Roques